Sign Up | Log In | What is SocialPicks?

Cell Therapeutics Inc (CTIC) Trade Now » Rate CTIC - Discuss CTIC - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

61.5%

Top:

20.0%

Rate CTIC:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

Who've Rated CTIC

All | Bullish | Bearish | Hold

Name	Rank	Rating	Return	Start	Closed
zerofootprint3@hotmail.com	N/A		-0.90%	11/20/09	--
gator-trader	N/A		+0.00%	11/12/09	11/12/09
mbmalone	N/A		+9.96%	10/30/09	--
mulder	N/A		+8.91%	10/29/09	--
hbnsprgr1	N/A		+19.57%	10/29/09	--
Mike Havrilla	73%		-19.57%	10/29/09	--
myjini	N/A		+4.35%	10/15/09	--
tired_ant	N/A		+1.79%	10/14/09	--
johny.nguyen	N/A		+1.79%	10/14/09	--
johny.nguyen	N/A		+0.00%	10/14/09	10/14/09
ancrimat	N/A		+0.90%	10/12/09	--
furqangilani	N/A		+0.90%	10/12/09	--
chlim	N/A		-0.90%	10/10/09	--
yehiel3	N/A		-0.90%	10/10/09	--
jgj	N/A		-3.51%	10/08/09	--
red728	N/A		-0.90%	10/07/09	--
amahmood23	N/A		-17.79%	10/07/09	--
fish72	N/A		-11.29%	09/29/09	--
stockexpert	N/A		+22.00%	09/26/09	11/05/09
carrier5	N/A		-25.17%	09/21/09	--

« previous
1
2
3
4
5
6
next »

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
WMT	WalMart Stores Inc
GLD	streetTRACKS Gold
RIMM	Research in Motion Ltd
YHOO	Yahoo! Inc
LEH	Lehman Brothers Holdings Inc
BA	The Boeing Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

StreetInsider.com on CTIC

Visit streetinsider.com

Discussion Wall

+ Add

amritadas (+0.00%)

A FREE report on the approval of a new Gout Drug - An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre

+	0 replies

stock_analyzer (+0.00% risk: conservative)

Chart Alerts for April 14 - Here is a link to some chart alerts for April 14th http://www.stockhideout.com/sas-nightly-chart-scans/2809-chart-alerts-april-14-a.html

+	0 replies

... more »

More Resources

About Cell Therapeutics Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.